ARTICLE | Company News
Chrysalis BioTechnology other research news
October 5, 1998 7:00 AM UTC
Chrysalis received a $100,000 Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to conduct formulation and preclinical feasibility studies with its Chry...